Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients with Acute Leukemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT04068597
What this trial is testing

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

Who this might be right for
Haematological MalignancyAcute Myeloid LeukemiaNon Hodgkin Lymphoma+3 more
CellCentric Ltd. 250
Not applicableNot Yet RecruitingNCT07831668
What this trial is testing

Real World Assessment of Venous Thromboembolic Risk in Hospitalized Patients With Acute Leukemia

Who this might be right for
Acute LeukemiaNewly Diagnosed Acute LeukemiaThromboprophylaxis+1 more
Gruppo Italiano Malattie EMatologiche dell'Adulto 250
Not applicableStudy completedNCT06030089
What this trial is testing

Plasma Dosage of Venetoclax in the Fup of AML Patients Treated With Aza + Ven

Who this might be right for
Acute Myeloid Leukemia
Centre Hospitalier Universitaire de Nice 20
Early research (Phase 1)Study completedNCT01399840
What this trial is testing

Study of BMN 673, a PARP Inhibitor, in Patients With Advanced Hematological Malignancies

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromeChronic Lymphocytic Leukemia+1 more
Pfizer 33
Early research (Phase 1)Study completedNCT00588991
What this trial is testing

Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders

Who this might be right for
Adult Acute Megakaryoblastic LeukemiaAdult Acute Monoblastic LeukemiaAdult Acute Monocytic Leukemia+20 more
National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)Looking for participantsNCT04905810
What this trial is testing

Azacitidine or Decitabine With Venetoclax for Acute Myeloid Leukemia With Prior Hypomethylating Agent Failure

Who this might be right for
Acute Myeloid LeukemiaRecurrent Acute Myeloid Leukemia
Brian Jonas 20
Early research (Phase 1)Looking for participantsNCT05679895
What this trial is testing

Safety and Efficacy of OC-1 Therapy in Patients With R/R T-ALL/LL

Who this might be right for
T-cell Acute Lymphoblastic LeukemiaLymphoblastic T-Cell Lymphoma
OneChain Immunotherapeutics 20
Not applicableStudy completedNCT00281801
What this trial is testing

Caregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow Transplantation

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
Case Comprehensive Cancer Center 168
Post-approval studies (Phase 4)Study completedNCT07773909
What this trial is testing

Venetoclax With Hypomethylating Agents in Newly Diagnosed AML Unfit for Intensive Chemotherapy

Who this might be right for
Acute Myeloid Leukemia
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 24
Post-approval studies (Phase 4)Study completedNCT00488709
What this trial is testing

Fludarabine, Cytarabine, Topotecan in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
PETHEMA Foundation 47
Testing effectiveness (Phase 2)Study completedNCT00003619
What this trial is testing

Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic Leukemia

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaMyelodysplastic Syndromes+1 more
Drexel University College of Medicine
Testing effectiveness (Phase 2)Study completedNCT00274807
What this trial is testing

Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Leukemia
The Cleveland Clinic 40
Testing effectiveness (Phase 2)Study completedNCT01252667
What this trial is testing

Clofarabine and Low-Dose Total-Body Irradiation in Treating Patients With Acute Myeloid Leukemia Undergoing Donor Peripheral Blood Stem Cell Transplant

Who this might be right for
Acute Myeloid Leukemia
Fred Hutchinson Cancer Center 44
Early research (Phase 1)Study completedNCT00624936
What this trial is testing

Azacytidine and Bortezomib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
Ohio State University Comprehensive Cancer Center 23
Early research (Phase 1)Study completedNCT01231919
What this trial is testing

MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Leukemias of Ambiguous LineageAcute Myeloid Leukemia/Transient Myeloproliferative Disorder+48 more
National Cancer Institute (NCI) 45
Not applicableStudy completedNCT04774744
What this trial is testing

Effect of Digital Health Coaching Program on Self-efficacy and Patient Reported Outcomes of Patients With Newly Diagnosed Acute Myeloid Leukemia or Chronic Lymphocytic Leukemia

Who this might be right for
Acute Myeloid LeukemiaChronic Lymphocytic Leukemia
M.D. Anderson Cancer Center 157
Testing effectiveness (Phase 2)Looking for participantsNCT05260528
What this trial is testing

CPX-351 vs Intensive Chemotherapy in Patients With de Novo Intermediate or Adverse Risk AML Stratified by Genomics

Who this might be right for
Acute Myeloid Leukemia
Centre Hospitalier Universitaire de Nice 248
Testing effectiveness (Phase 2)Temporarily pausedNCT02462265
What this trial is testing

Oshadi D & Oshadi R Combined With Salvage Chemotherapy for Relapsed Acute Myeloid Leukemia or Lymphoid Leukemia Patients

Who this might be right for
Acute Myeloid LeukemiaLymphoid Leukemia
Oshadi Drug Administration 15
Early research (Phase 1)Ended earlyNCT03588936
What this trial is testing

Nivolumab and Tocilizumab for Relapsed Hematological Malignancy Post-allogeneic Transplant

Who this might be right for
Acute LeukemiaChronic LeukemiaLymphoma+1 more
Medical College of Wisconsin 2
Early research (Phase 1)Ended earlyNCT00100971
What this trial is testing

Vaccine Therapy in Treating Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia
Boston Medical Center 9
Next Page